A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.
A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.
Not yet recruiting · NCT06886139 · Registry updated 2025-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL. | CD20-positive Diffuse Large B-Cell Lymphoma | Not yet recruiting | Phase 2 | 2025-08-22 | NCT06886139 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhejiang Teruisi Pharmaceutical Inc. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Sciences, Cancer Hospital | Beijing | China | 3 |